Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
57.1%
% of PBE's 28 holdings also in BBP
26.2%
% of BBP's 65 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 5.3% | 2.1% | 2.1% |
|
HALOZYME THERAPEUTICS INC | 3.1% | 2.1% | 2.1% |
|
TG THERAPEUTICS INC | 4.0% | 2.1% | 2.1% |
|
AMGEN INC | 5.0% | 2.0% | 2.0% |
|
PTC THERAPEUTICS INC | 2.9% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to BBP
|
NATERA INC | 5.4% |
|
ILLUMINA INC | 4.2% |
|
PROTAGONIST THERAPEUTICS, INC. | 4.1% |
|
NEUROCRINE BIOSCIENCES INC | 3.5% |
|
CATALYST PHARMACEUTICAL PART | 3.3% |
|
GILEAD SCIENCES INC | 3.2% |
|
BIOGEN IDEC INC | 3.1% |
|
UNITED THERAPEUTICS CORP | 3.1% |
|
AMGEN INC | 3.0% |
|
ROYALTY PHARMA PLC CLASS A | 3.0% |
PBE Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
BEIGENE LTD. SPONSORED ADR | -2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.2% |
|
SAGE THERAPEUTICS INC | -2.2% |
|
AXSOME THERAPEUTICS, INC. | -2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.1% |
|
BRIDGEBIO PHARMA, INC. | -1.9% |
|
ASCENDIS PHARMA A/S | -1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.7% |